Intriguingly, antidepressant-like effects of mGlu2 antagonists in mouse models of depression seem to involve BDNF release (48, 49), whereas we show in the present study that mGlu2 agonists transactivate TrkB in healthy mice through a distinct mechanism that is independent of BDNF release. Here, GRM2 is linked to depressive disorder.